article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. The full presentation is available at: [link].

Data 100
article thumbnail

Smartphone Sensor Data Could Detect Cannabis Intoxication With 90% Precision

Veriheal

The investigation assessed the suitability of using smartphone sensor data to detect cannabis intoxication, and it had promising results. ” Repurposing Smartphone Sensor Data. To detect the incidents of use among study subjects, information was gleaned from telephone surveys, phone sensor data, and self-reported cases.

Data 106
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4 Reasons Why Total Count Microbial Tests Are Poor Safety Indicators

Medicinal Genomics

The truth is that total count tests are not a good indicator of cannabis and hemp product safety for the following reasons: Pathogenic microbes may still be present Testing methods often do not agree Growers are discouraged from using beneficial microbes Growers are encouraged to use remediation. fumigatus, A.

Safety 92
article thumbnail

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Cannabis Law Report

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

article thumbnail

Cannabinoids, Influenza, and Coronavirus

Americans for Safe Access

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

article thumbnail

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

Cannabis Law Report

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52